biosimilars

Fresenius Kabi nabs smart infusion pump maker Ivenix for $240M

The drug producer Fresenius Kabi is taking its first steps under a new strategy to bolster its intravenous drug offerings.

Conor Hale Mar 31, 2022 12:36pm

Henlius falls short of IPO goal but still rakes in $410M on HKEX

Sep 18, 2019 10:40am

Sorrento sues Soon-Shiong over cancer drug 'catch-and-kill'

Apr 3, 2019 6:37pm

Innovent buys Chinese rights to Incyte drugs for $40M upfront

Dec 17, 2018 9:23am

Momenta calls time on biosimilar R&D

Oct 2, 2018 8:56am

Evolus plans $75M IPO to bring Botox biosimilar to market

Jan 10, 2018 5:36am